期刊文献+

肥厚性硬膜炎的临床诊治 被引量:6

原文传递
导出
摘要 肥厚性硬膜炎(hypertrophic pachymeningitis,HP)是一种以脑和/或脊髓硬膜局限性或弥漫性纤维性增厚为特征的中枢神经系统罕见疾病.按发病部位可分为肥厚性硬脑膜炎(hypertrophic cranial pachymeningitis,HCP)和肥厚性硬脊膜炎(hypertrophic spinal pachymeningitis,HSP).按病因HP可分为特发性和继发性两种形式.HSP由Charcot于1873年首次报道,而后Naffziger报道了首例特发性HCP[1].在不同类型的HP中,以特发性HCP最为多见.特发性HP的诊断需排除潜在的病因,而继发性HP病因多样,包括感染、自身免疫病、肿瘤、外伤等[2].MRI表现为硬膜增厚而需鉴别的疾病很多,且继发性HP病因多样,因而给HP的诊断带来一定挑战.
出处 《中华内科杂志》 CAS CSCD 北大核心 2016年第3期234-236,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献24

  • 1Bucy PC, Freeman LW. Hypertrophic spinal pachymeningitis with special reference to appropriate surgical treatment[J]. J Neurosurg, 1952, 9(6):564-578.
  • 2Dorr J, Elitok S, Dieste FJ, et al. Treatment-resistant chronic headaches and focal pachymeningitis in a 46-year-old man: a rare presentation of Wegener's granulomatosis[J]. Lancet Neurol, 2008, 7(4):368-372.
  • 3Yonekawa T, Murai H, Utsuki S,et al. A nationwide survey of hypertrophic pachymeningitis in Japan[J]. J Neurol Neurosurg Psychiatry, 2014, 85(7):732-739.
  • 4Zhao M, Geng T, Qiao L, et al. Idiopathic hypertrophic pachymeningitis : clinical, laboratory and neuroradiologic features in China[J]. J Clin Neurosci, 2014,21(7):1127-1132.
  • 5Shobha N,Mahadevan A,Taly AB,et al. Hypertrophic cranial pachymeningitis in countries endemic for tuberculosis : diagnostic and therapeutic dilemmas[J]. J Clin Neurosci, 2008,15(4):418-427.
  • 6Lu LX, Della-Torre E, Stone JH, et al. IgG4-related hypertrophic pachymeningitis : clinical features, diagnostic criteria, and treatment[J]. JAMA Neurol,2014,71(6):785-793.
  • 7Popkirov S, Kowalski T,Schlegel U, et al. Immunoglobulin-G4- related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab[J]. J Clin Neurosci, 2015,22(6):1038-1040.
  • 8Yokoseki A, Saji E, Arakawa M, et al. Hypertrophic pachymeningitis : significance of myeloperoxidase anti-neutrophil cytoplasmic antibody[J]. Brain, 2014, 137(Pt 2):520-536.
  • 9Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis[J]. N Engl J Med,2012,367(3):214-223.
  • 10Ralston DR, Marsh CB, Lowe MP, et al. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3,alphal-antitrypsin,and Fcgamma receptors [J]. J Clin Invest, 1997,100(6):1416-1424.

二级参考文献22

  • 1Masson C,Henin D,Hauw JJ,et al.Cranial pachymeningitis of unknown origin:a study of seven cases.Neurology,1993,43:1329-1334.
  • 2Parney IF,Johnson ES,Allen PB."Idiopathic" cranial hypertrophic pachymeningitis responsive to antituberculous therapy:case report.Neurosurgery,1997,41:965-971.
  • 3Murai H,Kira J,Kobayashi T,et al.Hypertrophic cranial pachymeningitis due to Aspergillus flavus.Clin Neurol Neurosurg,1992,94:247-250.
  • 4Takahashi K,Kobayashi S,Okada K,et al.Pachymeningitis with a perinuclear antineutrophil cytoplasmic antibody:response to pulse steroid.Neurology,1998,50:1190-1191.
  • 5Lee YC,Chueng YC,Hsu SW,et al.Idiopathic hypertrophic cranial pachymeningitis:case report with 7 years of imaging follow-up.AJNR Am J Neuroradiol,2003,24:119-123.
  • 6Kupersmith MJ,Martin V,Heller G,et al.Idiopathic hypertrophic pachymeningitis.Neurology,2004,62:686-694.
  • 7Saeki T,Fujita N,Kourakata H,et al.Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers.Clin Rheumatol,2004,23:76-80.
  • 8D′Andrea G,Trillo G,Celli P,et al.Idiopathic intracranial hypertrophic pachymeningitis:two case reports and review of the literature.Neurosurg Rev,2004,27:199-204.
  • 9Riku S,Kato S.Idiopathic hypertrophic pachymeningitis.Neuropathology,2003,23:335-344.
  • 10Lindstrom KM,Cousar JB,Lopes MB.IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria[J].Acta Neuropathol,2010,120:765-776.

共引文献72

同被引文献27

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部